Regenerative medicine is targeting developing and applying new treatments to heal tissues and organs and restore function lost because of aging, disease, damage or defects. It is also working to make solutions for organs that become permanently damaged.
1. Tissue Engineering and Biomaterials
Tissue engineering could also be a technique where biologically compatible scaffolds are implanted within the body at the situation where new tissue is to be formed. If the scaffold is within the geometric shape of the tissue that must be generated, and therefore the scaffold attracts cells the result is new tissue within the shape desired. If the newly forming tissue is subjected to exercise because it forms, the result are often new functional engineered issue.
2. Cellular Therapies
Our body uses stem cells together way of repairing itself. Studies have stated that if adult stem cells are harvested then injected at the site of diseased or damaged tissue, reconstruction of the tissue is possible under the proper circumstances. These cells are often collected from blood, fat, bone marrow, dental pulp, striated muscle and other sources. Cord blood provides yet one more source of adult stem cells. Scientists and clinicians are developing and refining their ability to arrange harvested stem cells to be injected into patients to repair diseased or damaged tissue.
3. Medical Devices and Artificial Organs
The clinical strategy is to transplant a replacement organ from a donor. The principal challenges are the supply of donor organs, and therefore the requirement that the donor take immunosuppression drugs—which have side effects. Further, there are many instances where the time to seek out an appropriate donor organ requires an interim strategy to support or supplement the function of the failing organ until a transplantable organ is found.
Title : Side effect free cancer chemotherapy by directed gene delivery using nanomaterials
A C Matin, Stanford University School of Medicine, United States
Title : Artificial intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : Novel gene therapy options for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Hebei University of Technology, China
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy